Bris­tol My­ers snaps up for­mer No­var­tis man­u­fac­tur­ing site in Illi­nois

Bris­tol My­ers Squibb plans to take over a No­var­tis plant in a Chica­go sub­urb to man­u­fac­ture its CAR-T ther­a­pies.

The com­pa­ny said Wednes­day it ex­e­cut­ed an agree­ment with No­var­tis to set up shop at its for­mer fa­cil­i­ty in Lib­er­tyville, Ill, with plans for the site to pro­duce vi­ral vec­tors for BMS’ CAR-T ther­a­pies.

The drug­mak­er did not dis­close the terms of the agree­ment to End­points News.

“We en­tered an agree­ment with No­var­tis to lease the fa­cil­i­ty and pur­chase the site’s as­sets. The ad­di­tion of this fa­cil­i­ty de­liv­ers on our dual-sourc­ing vec­tor strat­e­gy, which in­cludes in­ter­nal­iza­tion of vec­tor pro­duc­tion in ad­di­tion to work­ing with ex­ter­nal man­u­fac­tur­ers,” a BMS spokesper­son said in an email to End­points.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER